Baicalin reduces blood lipids and inflammation in patients with coronary artery disease and rheumatoid arthritis: a randomized, double-blind, placebo-controlled trial

BACKGROUND: Patients with rheumatoid arthritis (RA) have an increased risk of coronary artery disease (CAD) above the baseline. Baicalin possesses beneficial effects against both RA and CAD, but little is know on its clincial efficacy among patients manifesting both CAD and RA. METHODS: Three hundre...

Descripción completa

Detalles Bibliográficos
Autores principales: Hang, Yuanxing, Qin, Xian, Ren, Tianli, Cao, Jianing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6015450/
https://www.ncbi.nlm.nih.gov/pubmed/29935544
http://dx.doi.org/10.1186/s12944-018-0797-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6015450/
https://www.ncbi.nlm.nih.gov/pubmed/29935544
http://dx.doi.org/10.1186/s12944-018-0797-2

Ejemplares similares